Satisfactory Evaluation of Call Service Using AI After Ureteral Stent Insertion: Randomized Controlled Trial
Journal of Medical Internet Research · 2025
DOI: 10.2196/56039 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Medical Internet Research, 2025. Verfasst von Ukrae Cho und 10 weiteren Autor:innen. Beteiligte Einrichtung: AI product Biz Team, AI service division, SK Telecom, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Stents, Artificial Intelligence, Patient Satisfaction, Ureter. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Ureteral stents, such as double-J stents, have become indispensable in urologic procedures but are associated with complications like hematuria and pain. While the advancement of artificial intelligence (AI) technology has led to its increasing application in the health sector, AI has not been used to provide information on potential complications and to facilitate subsequent measures in the event of such complications.
Objective
This study aimed to assess the effectiveness of an AI-based prediction tool in providing patients with information about potential complications from ureteroscopy and ureteric stent placement and indicating the need for early additional therapy.
Methods
Overall, 28 patients (aged 20-70 years) who underwent ureteral stent insertion for the first time without a history of psychological illness were consecutively included. A “reassurance-call” service was set up to equip patients with details about the procedure and postprocedure care, to monitor for complications and their severity. Patients were randomly allocated into 2 groups, reassurance-call by AI (group 1) and reassurance-call by humans (group 2). The primary outcome was the level of satisfaction with the reassurance-call service itself, measured using a Likert scale. Secondary outcomes included satisfaction with the AI-assisted reassurance-call service, also measured using a Likert scale, and the level of satisfaction (Likert scale and Visual Analogue Scale [VAS]) and anxiety (State-Trait Anxiety Inventory and VAS) related to managing complications for both groups.
Results
Of the 28 recruited patients (14 in each group), 1 patient in group 2 dropped out. Baseline characteristics of patients showed no significant differences (all P>.05). Satisfaction with reassurance-call averaged 4.14 (SD 0.66; group 1) and 4.54 (SD 0.52; group 2), with no significant difference between AI and humans (P=.11). AI-assisted reassurance-call satisfaction averaged 3.43 (SD 0.94). Satisfaction about the management of complications using the Likert scale averaged 3.79 (SD 0.70) and 4.23 (SD 0.83), respectively, showing no significant difference (P=.14), but a significant difference was observed when using the VAS (P=.01), with 6.64 (SD 2.13) in group 1 and 8.69 (SD 1.80) in group 2. Anxiety about complications using the State-Trait Anxiety Inventory averaged 36.43 (SD 9.17) and 39.23 (SD 8.51; P=.33), while anxiety assessed with VAS averaged 4.86 (SD 2.28) and 3.46 (SD 3.38; P=.18), respectively, showing no significant differences. Multiple regression analysis was performed on all outcomes, and humans showed superior satisfaction than AI in the management of complications. Otherwise, most of the other variables showed no significant differences (P.>05).
Conclusions
This is the first study to use AI for patient reassurance regarding complications after ureteric stent placement. The study found that patients were similarly satisfied for reassurance calls conducted by AI or humans. Further research in larger populations is warranted to confirm these findings. Trial Registration Clinical Research Information System KCT0008062; https://tinyurl.com/4s8725w2
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- AI product Biz Team, AI service division, SK Telecom, Seoul, Republic of Korea.
- College of Business, KAIST, Seoul, Republic of Korea.
- Department of Urology, Soonchunhyang University Seoul Hospital, Soonchunhyang University Medical College, Seoul, Republic of Korea.
- Social Safety Net Team, ESG Office, SK Telecom, Seoul, Republic of Korea.
- Department of Engineering, University of Hong Kong, Hong Kong, China (Hong Kong).
- Department of Biomedical Informatics, College of Medicine, Konyang University, Daejeon, Republic of Korea.
ORCID-Profile: Ukrae Cho, Yong Nam Gwon, Seung Ryong Chong, Ji Yeon Han, Do Kyung Kim, Seung Whan Doo, Won Jae Yang, Kyeongmin Kim, Sung Ryul Shim, Jaehun Jung, Jae Heon Kim
Zitieren
APA
Cho, U., Gwon, Y. N., Chong, S. R., Han, J. Y., Kim, D. K., Doo, S. W., Yang, W. J., Kim, K., Shim, S. R., Jung, J., & Kim, J. H. (2025). Satisfactory Evaluation of Call Service Using AI After Ureteral Stent Insertion: Randomized Controlled Trial. Journal of Medical Internet Research. https://doi.org/10.2196/56039
Vancouver
Cho U, Gwon YN, Chong SR, Han JY, Kim DK, Doo SW, et al. Satisfactory Evaluation of Call Service Using AI After Ureteral Stent Insertion: Randomized Controlled Trial. Journal of Medical Internet Research. 2025. doi:10.2196/56039
BibTeX
@article{Cho2025,
author = {Cho, Ukrae and Gwon, Yong Nam and Chong, Seung Ryong and Han, Ji Yeon and Kim, Do Kyung and Doo, Seung Whan and Yang, Won Jae and Kim, Kyeongmin and Shim, Sung Ryul and Jung, Jaehun and Kim, Jae Heon},
title = {Satisfactory Evaluation of Call Service Using AI After Ureteral Stent Insertion: Randomized Controlled Trial},
journal = {Journal of Medical Internet Research},
year = {2025},
doi = {10.2196/56039}
}
EUVIMED